Organisations face increasing cybersecurity risks as digital footprints expand beyond traditional perimeters
12-18
SHANGHAI,Dec. 17,2024-- Nisun International Enterprise Development Group Co.,Ltd. ("Nisun International" or the "Company") (Nasdaq: NISN),a technology and industry driven integrate
12-18
Emmy Award-winning Actor-Producer Hiroyuki Sanada Named Recipient of the VES Award for Creative Excellence; Academy-Award winning Filmmaker Takashi YamazakiNamed Recipient of the VES Visionary Award
12-18
BENGALURU,India,Dec. 10,2024-- Tejas Networks (BSE: 540595) (NSE: TEJASNET) today announced that it has entered into a three - year contract with Vodafone Idea Limited ("VIL"),a leading tel
12-11
HONG KONG,Dec. 10,2024-- TheYidan Prize Foundation,the global philanthropic foundation behind the world\'s highest education accolade,hosted the 2024Yidan Prize Summit in Hong Kong on 9 December. The
12-11
BALI,Indonesia,Dec. 10,2024-- As the festive season unfolds,each Padma Hotels destination is embracing its own unique theme and programmes,from ocean-inspired celebrations to enchanting forest retreat
12-11
Enterprise and Community editions empower network defenders to see threats clearly and act confidently to protect their organizations
12-11
SINGAPORE,Dec. 10,2024--One World International School (OWIS) officially opened a first-of-its-kind Digital Campus on 9 December,with Ms Yeo Wan Ling,Member of Parliament of Pasir Ris-Punggol GRC,in a
12-11
– Collaboration combines Terumo\'sePRISM™ precision medicine software platform with Medis\' QFR® technology –
12-11
TAIPEI,Dec. 11,2024-- TAIPO Taiwan-Poland Chamber of Commerce and the Polish IoT & AI cluster SINOTAIC have signed a Memorandum of Understanding (MOU) to strengthen collaboration in satellite app
12-11
Bortala Mongolian Autonomous Prefecture 220 kV Xinhua South Gathering Station successfully delivered electricity
Designs For Health Inc. Held Liable For Infringement of Kaneka's Ubiquinol Patent
European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan
Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting
Health In Tech Announces Closing of Initial Public Offering
Higer New V Series, Leading Bus New Trend
©copyright 2009-2020 Diet Tips Daily
